Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_assertion type Assertion NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_head.
- NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_assertion description "[Of additional interest, we observed that the various colon cancer cell lines in general appear to express higher levels of cyclin B1 and also display higher sensitivity to Chk1 inhibitors, implying that Chk1 inhibitor may be more efficacious in treating colon cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_provenance.
- NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_assertion evidence source_evidence_literature NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_provenance.
- NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_assertion SIO_000772 18671143 NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_provenance.
- NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_assertion wasDerivedFrom befree-20150227 NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_provenance.
- NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_assertion wasGeneratedBy ECO_0000203 NP287811.RAIbDHRCG_YE9DB_0pC1kaNyGJcg6KlzvifPgX8OE9Phw130_provenance.